Connor, Clark & Lunn Investment Management Ltd. Hookipa Pharma Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$0.73 - $14.6 $2,970 - $59,407
-4,069 Reduced 18.41%
18,033 $14,000
Q3 2022

Nov 10, 2022
BUY
$1.27 - $15.0 $28,069 - $331,530
22,102 New
22,102 $30,000
Q4 2021

Feb 10, 2022
SELL
$2.33 - $5.94 $29,984 - $76,441
-12,869 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$5.89 - $9.35 $75,798 - $120,325
12,869 New
12,869 $76,000

Others Institutions Holding HOOK

# of Institutions
3
Shares Held
677K
Call Options Held
0
Put Options Held
0
View Full List

About HOOKIPA Pharma Inc.

HOOK Quotes by TradingView
  • Ticker HOOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,654,500
  • Market Cap $155M
  • Description
  • HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...
More about HOOK
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email